A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid …

…, MW Greenwald, S Block, WJ Shergy… - Annals of the …, 2004 - ard.bmj.com
Objective: To assess the efficacy and safety of 100 mg daily anakinra (Kineret), a recombinant
form of the naturally occurring interleukin 1 receptor antagonist, plus methotrexate (MTX) …

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a …

MW Greenwald, WJ Shergy, JL Kaine… - Arthritis & …, 2011 - Wiley Online Library
Objective To assess the safety of rituximab in combination with a tumor necrosis factor (TNF)
inhibitor and methotrexate (MTX) in patients with rheumatoid arthritis (RA). Methods Adult …

Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis

WJ Shergy, RP Polisson, DS Caldwell, JR Rice… - The American journal of …, 1988 - Elsevier
Purpose: Beginning in the 1980s, methotrexate has been used successfully to treat
rheumatoid arthritis. The magnitude and severity of short- and long-term methotrexate toxicity, …

Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.

WJ Shergy, RA Isern, DA Cooley… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To assess the timing of onset of clinical benefit following the initial infusion of
infliximab and to obtain additional safety experience of infliximab when given in an office …

Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

PD Miller, WJ Shergy, JJ Body, P Chen… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To compare the effects on back pain of teriparatide versus alendronate, we
analyzed the reporting of back pain in a head to head comparator trial and a followup study. …

Infliximab in the treatment of recalcitrant idiopathic orbital inflammation

MW Wilson, WJ Shergy, BG Haik - Ophthalmic Plastic & …, 2004 - journals.lww.com
A 15-year-old boy had bilateral idiopathic orbital inflammation refractory to treatment with
corticosteroids. He was not only unresponsive to subsequent therapy with methotrexate but …

Polymyositis after propylthiouracil treatment for hyperthyroidism.

WJ Shergy, DS Caldwell - Annals of the rheumatic diseases, 1988 - ard.bmj.com
An additional disorder in the spectrum of thyroid related muscle disease is presented.
Hypothyroid and hyperthyroid disease are both associated with a variety of muscle abnormalities, …

Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis

WJ Shergy - Seminars in arthritis and rheumatism, 2009 - Elsevier
OBJECTIVES: To highlight the importance of improving quality of life (QoL) in patients with
rheumatoid arthritis (RA) and to provide a summary of the QoL benefits provided by abatacept …

Acute gouty arthritis and intravenous nitroglycerin

WJ Shergy, GS Gilkeson… - Archives of internal …, 1988 - jamanetwork.com
• Four adult patients with unstable angina were treated with intravenous nitroglycerin in the
coronary intensive care unit. All four patients experienced an acute gouty flare while …

Assessing the feasibility of the effectiveness of discontinuing bisphosphonates trial: a pilot study

…, JA Melnick, ME Lewiecki, WJ Shergy… - Osteoporosis …, 2017 - Springer
The Effectiveness of Discontinuing Bisphosphonates (EDGE) study is a planned pragmatic
clinical trial to guide “drug holiday” clinical decision making. This pilot study assessed work …